Bifidobacterium longum affects the methylation level of forkhead box P3 promoter in 2, 4, 6-trinitrobenzenesulphonic acid induced colitis in rats

Xavier, 2007, Unravelling the pathogenesis of inflammatory bowel disease, Nature, 448, 427, 10.1038/nature06005 Ghosh, 2011, Colonic microbiota alters host susceptibility to infectious colitis by modulating inflammation, redox status, and ion transporter gene expression, Am. J. Physiol. Gastrointest. Liver Physiol., 301, 39, 10.1152/ajpgi.00509.2010 Cooney, 2010, NOD2 stimulation induces autophagy in dendritic cells influencing bacterial handling and antigen presentation, Nat. Med., 16, 90, 10.1038/nm.2069 Scharl, 2012, Inflammatory bowel disease pathogenesis: what is new?, Curr. Opin. Gastroenterol., 28, 301, 10.1097/MOG.0b013e328353e61e Steck, 2012, Bacterial proteases in IBD and IBS, Gut, 61, 1610, 10.1136/gutjnl-2011-300775 Blumberg, 2000, Animal models of mucosal inflammation and their relation to human inflammatory bowel disease, Curr. Opin. Immunol., 11, 548 Linskens, 2001, The bacterial flora in inflammatory bowel disease: current insights in pathogenesis and the influence of antibiotics and probiotics, Scand. J. Gastroenterol., 36, 29, 10.1080/003655201753265082 Ventura, 2014, Bifidobacteria and humans: our special friends, from ecological to genomics perspectives, J. Sci. Food Agric., 94, 163, 10.1002/jsfa.6356 Bibiloni, 2005, VSL|[num]|3 probiotic-mixture induces remission in patients with active ulcerative colitis, Am. J. Gastroenterol., 100, A377, 10.1111/j.1572-0241.2005.41794.x Verbeke, 2014, Modulating the microbiota in inflammatory bowel diseases: prebiotics, probiotics or faecal transplantation?, Proc. Nutr. Soc., 73, 490, 10.1017/S0029665114000639 Yao, 2011, Treatment of mice with dextran sulfate sodium-induced colitis with human Interleukin 10 secreted by transformed Bifidobacterium longum, Mol. Pharm., 8, 488, 10.1021/mp100331r Foligne, 2007, Correlation between in vitro and in vivo immunomodulatory properties of lactic acid bacteria, World J. Gastroenterol., 13, 236, 10.3748/wjg.v13.i2.236 Kwon, 2010, Generation of regulatory dendritic cells and CD4+Foxp3+ T cells by probiotics administration suppresses immune disorders, Proc. Natl. Acad. Sci. U. S. A., 107, 2159, 10.1073/pnas.0904055107 Sakaguchi, 2006, Foxp3 + CD25 + CD4 + natural regulatory T cells in dominant self-tolerance and autoimmune disease, Immunol. Rev., 212, 8, 10.1111/j.0105-2896.2006.00427.x Zou, 2006, Regulatory T cells, tumour immunity and immunotherapy, Nat. Rev. Immunol., 6, 295, 10.1038/nri1806 Janson, 2008, FOXP3 promoter demethylation reveals the committed Treg population in humans, Plos One, 3, e1612-e, 10.1371/journal.pone.0001612 Miyara, 2009, Functional delineation and differentiation dynamics of human CD4+ T cells expressing the FoxP3 transcription factor, Immunity, 30, 899, 10.1016/j.immuni.2009.03.019 Zhang, 2006, Curcumin inhibits trinitrobenzene sulphonic acid-induced colitis in rats by activation of peroxisome proliferator-activated receptor gamma, Int. Immunopharmacol., 6, 1233, 10.1016/j.intimp.2006.02.013 Ogino, 2011, CD4+CD25+ regulatory T cells suppress Th17-responses in an experimental colitis model, Dig. Dis. Sci., 56, 376, 10.1007/s10620-010-1286-2 Himmel, 2012, Regulatory T-cell therapy for inflammatory bowel disease: more questions than answers, Immunology, 136, 115, 10.1111/j.1365-2567.2012.03572.x Triantafillidis, 2011, Current and emerging drugs for the treatment of inflammatory bowel disease, Drug Des. Dev. Ther., 5, 185, 10.2147/DDDT.S11290 Favier, 1997, Fecal beta-D-galactosidase production and Bifidobacteria are decreased in Crohn's disease, Dig. Dis. Sci., 42, 817, 10.1023/A:1018876400528 Schwiertz, 2010, Microbiota in pediatric inflammatory bowel disease, J. Pediatr., 157, 240, 10.1016/j.jpeds.2010.02.046 Elmer, 1996, Biotherapeutic agents. A neglected modality for the treatment and prevention of selected intestinal and vaginal infections, Jama J. Am. Med. Assoc., 275, 870, 10.1001/jama.1996.03530350052034 Orrhage, 1994, Binding of mutagenic heterocyclic amines by intestinal and lactic acid bacteria, Mutat. Res., 311, 239, 10.1016/0027-5107(94)90182-1 Garrido, 2013, Utilization of galactooligosaccharides by Bifidobacterium longum subsp. infantis isolates, Food Microbiol., 33, 262, 10.1016/j.fm.2012.10.003 Furrie, 2005 Srutkova, 2015, Bifidobacterium longum CCM 7952 promotes epithelial barrier function and prevents acute DSS-induced colitis in strictly strain-specific manner, Plos One, 10 Schwarzer, 2013, Neonatal colonization of germ-free mice with Bifidobacterium longum prevents allergic sensitization to major birch pollen allergen Bet v 1, Vaccine, 31, 5405, 10.1016/j.vaccine.2013.09.014 Schabussova, 2011, Distinctive anti-allergy properties of two probiotic bacterial strains in a mouse model of allergic poly-sensitization, Vaccine, 29, 1981, 10.1016/j.vaccine.2010.12.101 Elian, 2014, Bifidobacterium longum subsp. infantis BB-02 attenuates acute murine experimental model of inflammatory bowel disease, Benef. Microbes, 6, 1 Qiu, 2013, Faecalibacterium prausnitzii upregulates regulatory T cells and anti-inflammatory cytokines in treating TNBS-induced colitis, J. Crohn's Colitis, 7, e558, 10.1016/j.crohns.2013.04.002 Bettelli, 2006, Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells, Nature, 441, 235, 10.1038/nature04753 Sakaguchi, 2007, Emerging challenges in regulatory T cell function and biology, Science, 317, 627, 10.1126/science.1142331 Uhlig, 2006, Characterization of Foxp3+CD4+CD25+ and IL-10-secreting CD4+CD25+ T cells during cure of colitis, J. Immunol., 177, 5852, 10.4049/jimmunol.177.9.5852 Di, 2005, Probiotics ameliorate recurrent Th1-mediated murine colitis by inducing IL-10 and IL-10-dependent TGF-beta-bearing regulatory cells, J. Immunol., 174, 3237, 10.4049/jimmunol.174.6.3237 Annamaria Pronio, 2008, Probiotic administration in patients with ileal pouch–anal anastomosis for ulcerative colitis is associated with expansion of mucosal regulatory cells, Inflamm. Bowel Dis., 14, 662, 10.1002/ibd.20369 Ziegler SF. FOXP3: Of Mice and Men - Annual Review of Immunology, 24(1):209. Regulatory T Cell Autoimmunity Forkhead Transcription Factor. Khattri, 2003, An essential role for Scurfin in CD4+CD25+ T regulatory cells, Nat. Immunol., 4, 337, 10.1038/ni909 Fontenot, 2003, Foxp3 programs the development and function of CD4+CD25+ regulatory T cells, Nat. Immunol., 4, 330, 10.1038/ni904 Yagi, 2004, Crucial role of FOXP3 in the development and function of human CD25+CD4+ regulatory T cells, Int. Immunol., 16, 1643, 10.1093/intimm/dxh165